Agios Pharmaceuticals Inc

Company Snapshot
88 Sidney Street
Cambridge, MA 02139
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 393
https://www.agios.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$200,391,000
$12,536,000
Operating Income
($316,149,000)
($378,418,000)
($389,047,000)
Net Income
($327,370,000)
$1,604,715,000
($231,801,000)
2020
Gross Profit
$200,391,000
Operating Income
($316,149,000)
Net Income
($327,370,000)
2021
Gross Profit
Operating Income
($378,418,000)
Net Income
$1,604,715,000
2022
Gross Profit
$12,536,000
Operating Income
($389,047,000)
Net Income
($231,801,000)
The above data on Agios Pharmaceuticals Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Brian Goff
Chief Executive Officer and Director
$753,539
$10,981,074
$9,834
$11,744,447
Brian Goff
$11,744,447
Chief Executive Officer and Director
Jacqualyn Fouse
Chairman of the Board
$803,461
$4,141,027
$10,311
$4,954,799
Jacqualyn Fouse
$4,954,799
Chairman of the Board
Cecilia Jones
Chief Financial Officer
$398,934
$2,507,570
$4,422
$2,910,926
Cecilia Jones
$2,910,926
Chief Financial Officer
Sarah Gheuens
Chief Medical Officer and Head of Research and Development
$755,250
$1,077,700
$13,953
$1,846,903
Sarah Gheuens
$1,846,903
Chief Medical Officer and Head of Research and Development
James Burns
Chief Legal Officer
$646,300
$1,077,700
$14,025
$1,738,025
James Burns
$1,738,025
Chief Legal Officer
Agios Pharmaceuticals Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us